Effects of CTCF on Human Liver Cancer Stem Cells and Cell Proliferation

LIU Qiu-ying, XIE Xiao-yan, WEI Ling, WANG He. et al

Abstract

To explore the effects of CCCTC-binding factor (CTCF) on human liver cancer stem cells (HepG2) and cell proliferation of HepG2 and Nasopharyngeal carcinoma cell line (CNE1). Methods The pEGFP-N1/CTCF、CTCF-shRNA and GFP-shRNA plasmids were constructed and transfected into HepG2 and CNE1 cells, and RT-PCR or Western blot were performed to detect the mRNA or protein levels of CTCF. The subpopulation of CD90+ cancer stem cells in HepG2 cells transfected with CTCF-shRNA plasmid or GFP-shRNA plasmid (as transfection control) were assayed by flow cytometry with the wild type HepG2 cells as control. Proliferation of cells transfected with CTCF-overexpression orCTCF-shRNA plasmid was evaluated by MTT assay. Results The levels of both mRNA and protein of CTCF were increased in pEGFP-N1/CTCF transfected HepG2 and CNE1 cells compared to that in pEGFP-N1 transfected cells (P <0.05), and decreased in CTCF-shRNA transfected cells compared to that in cells transfected with GFP-shRNA (P<0.05). The results of flow cytometry demonstrated that, detection rate of CD90+ cells in cells transfected with CTCF-shRNA plasmid 〔(1.733 0±0.417 7)%〕was obviously higher than that of wild-type HepG2 cells 〔(0.575 0±0.062 9)%〕 and cells transfected with GFP-shRNA plasmid 〔(0.350 0±0.086 6)%〕 (P<0.05). The results of MTT analysis showed that, alteration of CTCF had no effect on cancer cell proliferation (P>0.05). Conclusion CTCF inhibits human liver cancer stem cells but no effect on cell proliferation.

 

Keywords: CTCF, Human liver cancer stem cells, Cell viability 

 

Full Text:

PDF


References


Phillips JE, Corces VG. CTCF:master weaver of the genome. Cell,2009; 137(7); 1194-1211.

Mishra L, Banker T, Murray J, et al. Liver stem cells and hepatocellular carcinoma. Hepatology,2009;49( 1) ;318-329.

Yang ZF, Ho DW, Ng MN, et al. Significance of CD90 + cancer stem cells in human liver cancer. Cancer Cell. 2008; 13 (2): 153-166.

Yang ZF, Ngai P, Ho DW, et al. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology,2008;47(3) ;919-928.

Meeran SM, Patel SN, Tollefsbol TO. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One,2010;5(7) ;el 1457.

De Bari С, Dell’Accio F, Tylzanowski P, et al. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum,2001;44(8); 1928-1942.

Maitra B, Szekely E, Gjini K, et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant, 2004, 33 (6): 597-604.

Yazawa T, Mizutani T, Yamada K. et al. Differentiation of adult stem cells derived from hone marrow stroma into Leydig or adrenocortical cells. Endocrinology, 2006; 147 ( 9 ): 4104- 4111.

Gondo S, Okabe T, Tanaka T, et al. Adipose tissue-derived and bone marrow-derived mesenchymal cells develop into different lineage of steroidogenic cells by forced expression of steroidogenic factor 1. Endocrinology, 2008; 149 (9); 4717- 4725.

Sriraman V, Sairam MR. Rao AJ. Evaluation of relative roles of LH and FSH in regulation of differentiation of Leydig cells using an ethane 1, 2-dimethylsulfonate-treated adult rat model. J Endocrinol,2003; 176(1): 151-1611.

Morris ID. Leydig cell resistance to the cytotoxic effect of ethylene dimethanesulphonate in the adult rat testis. J Endocrinol, 1985; 105(3); 311-316.

Bakalska M, Atanassova N, Koeva Y, et al. Induction of male germ cell apoptosis by testosterone withdrawal after ethane dimethanesulfonate treatment in adult rats. Endocr Regul, 2004;38(3) : 103-110.

Jackson AE, O’Leary PC, Ayers MM, et al. The effects of ethylene dimethane sulphonate (EDS) on rat Leydig cells: evidence to support a connective tissue origin of Leydig cells. Biol Reprod, 1986;35(2):425-437.

Gabory A, Jammes Н. Dandolo L. The H19 locus; role of an imprinted non-coding RNA in growth and development. Bioessays, 2010; 32 ( 6): 4 73-480.

Nativio R, Wendt KS, Ito Y, et al. Cohesin is required for higher-order chromatin conformation at the imprinted IGF2- H19 locus. PLoS Genet,2009;5( 11) ;el000739.

Yao H, Brick K, Evrard Y, et al. Mediation of CTCF transcriptional insulation by DEAD-box RNA-binding protein p68 and steroid receptor RNA activator SRA. Gene Dev*2010; 24(22):2543-2555.

Ratajczak MZ. Igf2-H19, an imprinted tandem gene, is an important regulator of embryonic development, a guardian of proliferation of adult pluripotent stem cells, a regulator of longevity, and a * passkey, to cancerogenesis. Folia Histochem Cytobiol,2012; 50( 2); 171-179.

Wu J, Qin Y, Li B, et al. Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma. Genomics,2008;91(5):443-450.

Wan LB. Pan H. Hannenhalli S. et al. Maternal depletion of CTCF reveals multiple functions during oocyte and preimplantation embryo development. Development»2008; 135 (16):2729-2738.

Heath H. De Almeida CR, Sleutels F. et al. CTCF regulates cell cycle progression of T cells in the thymus. EMBO J, 2008;27(21):2839-2850.

Torrano V, Chernukhin I, Docquier F, et al. CTCF regulates growth and erythroid differentiation of human myeloid leukemia cells. J Biol Chem,2005;280(30); 28152-28161.

Rasko JEJ, Klewwa EM, Leon J, et al. Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF. Cancer Res, 2001; 61 (16): 6002-6007.


Refbacks

  • There are currently no refbacks.